US Swing-Trading: Best STOCKS to buy
All Stocks on our watchlist are absolute top picks and fulfill Minervini's Trend-Template criteria and are selected using IBD's CAN SLIM criteria. Also, they all have low risk entry points.
https://www.tradingview.com/watchlists/75013711/
Featuring a few stocks:
PBH
With its next quarterly earnings report set for around Aug. 4, Prestige Brands (PBH) is trading approximately 10% shy of its all time highs. The stocks built a low risk entry in this range which we would call a cup with low-handle pattern.
Swing-Traders can build a first smaller position in this range and then add to the position as the stock enters new all time highs.
The entry is based on a first-stage consolidation.
Understand that buying a stock just ahead of earnings involves risk since you typically don't have enough time to build a profit cushion before the latest quarterly numbers come out. Be sure to follow sound buy and sell rules to minimize your exposure.
Prestige Brands reported 15% EPS growth in its most recent report. Sales gains came in at 12%.
Analysts are looking for earnings growth of -8% for the quarter, and 3% growth for the full year. Annual growth estimates were recently revised lower.
MCK
Mckesson (MCK) is forming a base offering a 340.04 buy point with its next quarterly report expected on Aug. 3. The entry is based on a second-stage flat base.
Keep in mind that jumping into a stock right as it gets ready to report means you likely won't have enough time to build a profit cushion before the release. That leaves you exposed to a sudden downturn if the company disappoints investors with poor numbers and/or weak guidance. You can reduce your exposure by waiting to see the actual numbers and the market's reaction. Using an options strategy during earnings season is another way to put yourself in a position to profit, while minimizing the potential downside.
Earnings growth dropped last quarter from 34% to 15%. But revenue moved higher, from 10% to 12%.
Consensus analyst estimates call for EPS growth of -5% for the quarter, and an -1% gain for the full year.
The company has a 97 Composite Rating and holds the No. 1 rank among its peers in the Medical-Wholesale Drugs industry group. Amerisourcebergen (ABC) and Cardinal Health (CAH) are also among the group's highest-rated stocks.
https://www.tradingview.com/watchlists/75013711/
Featuring a few stocks:
PBH
With its next quarterly earnings report set for around Aug. 4, Prestige Brands (PBH) is trading approximately 10% shy of its all time highs. The stocks built a low risk entry in this range which we would call a cup with low-handle pattern.
Swing-Traders can build a first smaller position in this range and then add to the position as the stock enters new all time highs.
The entry is based on a first-stage consolidation.
Understand that buying a stock just ahead of earnings involves risk since you typically don't have enough time to build a profit cushion before the latest quarterly numbers come out. Be sure to follow sound buy and sell rules to minimize your exposure.
Prestige Brands reported 15% EPS growth in its most recent report. Sales gains came in at 12%.
Analysts are looking for earnings growth of -8% for the quarter, and 3% growth for the full year. Annual growth estimates were recently revised lower.
MCK
Mckesson (MCK) is forming a base offering a 340.04 buy point with its next quarterly report expected on Aug. 3. The entry is based on a second-stage flat base.
Keep in mind that jumping into a stock right as it gets ready to report means you likely won't have enough time to build a profit cushion before the release. That leaves you exposed to a sudden downturn if the company disappoints investors with poor numbers and/or weak guidance. You can reduce your exposure by waiting to see the actual numbers and the market's reaction. Using an options strategy during earnings season is another way to put yourself in a position to profit, while minimizing the potential downside.
Earnings growth dropped last quarter from 34% to 15%. But revenue moved higher, from 10% to 12%.
Consensus analyst estimates call for EPS growth of -5% for the quarter, and an -1% gain for the full year.
The company has a 97 Composite Rating and holds the No. 1 rank among its peers in the Medical-Wholesale Drugs industry group. Amerisourcebergen (ABC) and Cardinal Health (CAH) are also among the group's highest-rated stocks.
Combing the BEST of two WORLD's: Cathie Wood & Mark Minervini
